Cargando…
Pegylated interferon-alpha-2a for the treatment of ocular surface squamous neoplasia
Ocular surface squamous neoplasia (OSSN) is the most common nonpigmented ocular surface neoplasm. Interferon-alpha (IFNα)-2b has been proved to be an effective immunotherapeutic agent to treat OSSN. We have used intralesional and topical (36 μg/ml) pegylated (peg) IFNα-2a to treat a recurrent surgic...
Autores principales: | Nuruddin, Murtuza, Roy, Soma Rani, Hoque, Fahmida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979401/ https://www.ncbi.nlm.nih.gov/pubmed/35388258 http://dx.doi.org/10.4103/ojo.ojo_146_21 |
Ejemplares similares
-
Diffuse large cell lymphoma of the lacrimal sac may mimic as acute dacryocystitis
por: Roy, Soma Rani, et al.
Publicado: (2023) -
Interferon alpha-2b in giant ocular surface squamous neoplasia
por: Hernandez-Bogantes, Erick, et al.
Publicado: (2016) -
Recombinant Interferon Alpha-2b as Primary Treatment for Ocular Surface Squamous Neoplasia
por: Ghaffari, Reza, et al.
Publicado: (2021) -
Effect of Pegylated Interferon and Mitomycin C on Ocular Surface Squamous Neoplasia in Xeroderma Pigmentosum: A Case Series
por: Dirar, Qais S., et al.
Publicado: (2020) -
Relapsed ocular squamous surface neoplasia treated with topical interferon alfa-2b
por: Rocha-de-Lossada, Carlos, et al.
Publicado: (2020)